Biophytis S.A.
Biophytis S.A., a clinical-stage biotechnology company, focuses on the development of therapeutics that slow the degenerative processes and improve functional outcomes for patients suffering from age-related diseases. Its therapeutics targets and activates key biological resilience pathways that can protect against and counteract the effects of the multiple biological and environmental stresses, … Read more
Biophytis S.A. (BPTSY) - Total Assets
Latest total assets as of June 2024: $8.71 Million USD
Based on the latest financial reports, Biophytis S.A. (BPTSY) holds total assets worth $8.71 Million USD as of June 2024.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Biophytis S.A. - Total Assets Trend (2012–2023)
This chart illustrates how Biophytis S.A.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Biophytis S.A. - Asset Composition Analysis
Current Asset Composition (December 2023)
Biophytis S.A.'s total assets of $8.71 Million consist of 74.0% current assets and 26.0% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 46.6% |
| Accounts Receivable | $2.74 Million | 22.9% |
| Inventory | $45.00K | 0.4% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $2.64 Million | 22.1% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2012–2023)
This chart illustrates how Biophytis S.A.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Biophytis S.A.'s current assets represent 74.0% of total assets in 2023, a decrease from 95.4% in 2012.
- Cash Position: Cash and equivalents constituted 46.6% of total assets in 2023, down from 51.5% in 2012.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 22.0% of total assets, an increase from 0.0% in 2012.
- Asset Diversification: The largest asset category is accounts receivable at 22.9% of total assets.
Biophytis S.A. Competitors by Total Assets
Key competitors of Biophytis S.A. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
MedPacto Inc
KQ:235980
|
Korea | ₩51.58 Billion |
|
2H0
F:2H0
|
Germany | €15.27 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
|
Hualan Biological EngineeringInc
SHE:002007
|
China | CN¥16.27 Billion |
Biophytis S.A. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Biophytis S.A. generates 0.00x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Biophytis S.A. is currently not profitable relative to its asset base.
Biophytis S.A. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.41 | 0.81 | 0.72 |
| Quick Ratio | 0.41 | 0.80 | 0.72 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-8.35 Million | $ -2.68 Million | $ -5.71 Million |
Biophytis S.A. - Advanced Valuation Insights
This section examines the relationship between Biophytis S.A.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.26 |
| Latest Market Cap to Assets Ratio | 0.35 |
| Asset Growth Rate (YoY) | -45.6% |
| Total Assets | $11.96 Million |
| Market Capitalization | $4.19 Million USD |
Valuation Analysis
Below Book Valuation: The market values Biophytis S.A.'s assets below their book value (0.35 x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Biophytis S.A.'s assets decreased by 45.6% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Biophytis S.A. (2012–2023)
The table below shows the annual total assets of Biophytis S.A. from 2012 to 2023.
| Year | Total Assets | Change |
|---|---|---|
| 2023-12-31 | $11.96 Million | -45.60% |
| 2022-12-31 | $21.99 Million | -39.37% |
| 2021-12-31 | $36.26 Million | +33.27% |
| 2020-12-31 | $27.21 Million | +53.97% |
| 2019-12-31 | $17.67 Million | -19.17% |
| 2018-12-31 | $21.86 Million | -15.74% |
| 2017-12-31 | $25.95 Million | +209.15% |
| 2016-12-31 | $8.39 Million | -37.91% |
| 2015-12-31 | $13.52 Million | +3393.95% |
| 2014-12-31 | $386.86K | -38.38% |
| 2013-12-31 | $627.76K | -48.11% |
| 2012-12-31 | $1.21 Million | -- |